burger menu open
search-icon
Search Tile About us Search Tile Newsroom
Search Tile Careers Search Tile Investor Relations
Search Tile Sustainability
Loading...

Why invest in Redcare?

News

05/11/2024
Redcare Pharmacy: strong Q3 growth combined with 2% adj. EBITDA margin. Rx momentum in Germany further increased, with sales growth of over 130% in October.
Go
Financial News
03/10/2024
Redcare Pharmacy achieves 81% growth in Q3 Rx sales in Germany, 108% in September and decides to accelerate marketing based on very convincing e-Rx metrics.
Go
Financial News
03/10/2024
Redcare Pharmacy achieves 81% growth in Q3 Rx sales in Germany, 108% in September and decides to accelerate marketing in Q4 based on very convincing e-Rx metrics. Full-year guidance updated.
Go
Ad-hoc
View all

Publications

File icon
Q3 statement / Q3 financial report 2024
Quarterly Reports 05/11/2024 10.81 MB
Download
File icon
Presentation Trading Update Q3 2024
Quarterly Reports 03/10/2024 1.82 MB
Download
View all

Calendar

11 Mar
Publication Annual Financial Report
Add to calendar
06 May
Publication Quarterly Statement (call-date Q1)
Add to calendar
View all

Financial by the numbers

0 $

Lorem ipsum

0 $

Lorem ipsum

0 $

Lorem ipsum

0 $

Lorem ipsum

0 $

Lorem ipsum

Facts & Figures as of 2023

Redcare in numbers

Data
10,8   m

Active Customers
(6-fold increase since 2016)

Data
EUR 1,8   bn

Sales
(10-fold increase since 2016)

Data
> 29   m

Orders
(7-fold increase since 2016)

Net Promoter Score (NPS)

Avg. value for 2023

Fact Sheet

Download

Investment Case

Download

ESG

Discover our approach

Stay up to date

If you want to receive news from Redcare Pharmacy, such as corporate news or financial reports, please register below.

Receive Notifications

Want to know more?

Get in touch and send us an email.

Do you have any feedback or questions?
We are happy to hear from you.

headset-icon

Monica Ambrosi

Associate Director, Investor Relations

investors@redcare-pharmacy.com